Associations between lifetime classic psychedelic use and markers of physical health

被引:45
作者
Simonsson, Otto [1 ]
Sexton, James D. [2 ]
Hendricks, Peter S. [3 ]
机构
[1] Univ Oxford, Dept Sociol, 42-43 Pk End St, Oxford OX1 2JD, England
[2] Imperial Coll London, Dept Brain Sci, London, England
[3] Univ Alabama Birmingham, Dept Hlth Behav, Birmingham, AL USA
关键词
Classic psychedelics; psilocybin; LSD; health; body mass index; cancer; heart disease; MENTAL-HEALTH; POPULATION; PSILOCYBIN; MORTALITY; DIMETHYLTRYPTAMINE; ALCOHOL; TOBACCO; DRUGS; AGE;
D O I
10.1177/0269881121996863
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: In recent years, there has been significant research on the mental health effects of classic psychedelic use, but there is very little evidence on how classic psychedelics might influence physical health. Aims: The purpose of the present study was to investigate the associations between lifetime classic psychedelic use and markers of physical health. Methods: Using data from the National Survey on Drug Use and Health (2015-2018) with 171,766 (unweighted) adults aged 18 or above in the United States, the current study examined the associations between lifetime classic psychedelic use and three markers of physical health (self-reported overall health, body mass index, and heart condition and/or cancer in the past 12 months) while controlling for a range of covariates. Results: Respondents who reported having tried a classic psychedelic at least once in their lifetime had significantly higher odds of greater self-reported overall health and significantly lower odds of being overweight or obese versus having a normal weight. The association between lifetime classic psychedelic use and having a heart condition and/or cancer in the past 12 months approached conventional levels of significance, with lower odds of having a heart condition and/or cancer in the past 12 months for respondents who had tried a classic psychedelic at least once. Conclusion: The results of the present study suggest that classic psychedelics may be beneficial to physical health. Future research should investigate the causal effects of classic psychedelics on physical health and evaluate possible mechanisms.
引用
收藏
页码:447 / 452
页数:6
相关论文
共 52 条
  • [1] Long-term effects of psychedelic drugs: A systematic review
    Aday, Jacob S.
    Mitzkovitz, Cayla M.
    Bloesch, Emily K.
    Davoli, Christopher C.
    Davis, Alan K.
    [J]. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2020, 113 : 179 - 189
  • [2] [Anonymous], 2019, 2018 National Survey on Drug Use and Health: Methodological Summary and Definitions
  • [3] The Australian drug harms ranking study
    Bonomo, Yvonne
    Norman, Amanda
    Biondo, Sam
    Bruno, Raimondo
    Daglish, Mark
    Dawe, Sharon
    Egerton-Warburton, Diana
    Karro, Jonathan
    Kim, Charles
    Lenton, Simon
    Lubman, Dan I.
    Pastor, Adam
    Rundle, Jill
    Ryan, John
    Gordon, Paul
    Sharry, Patrick
    Nutt, David
    Castle, David
    [J]. JOURNAL OF PSYCHOPHARMACOLOGY, 2019, 33 (07) : 759 - 768
  • [4] Psilocybin with psychological support for treatment-resistant depression: six-month follow-up
    Carhart-Harris, R. L.
    Bolstridge, M.
    Day, C. M. J.
    Rucker, J.
    Watts, R.
    Erritzoe, D. E.
    Kaelen, M.
    Giribaldi, B.
    Bloomfield, M.
    Pilling, S.
    Rickard, J. A.
    Forbes, B.
    Feilding, A.
    Taylor, D.
    Curran, H. V.
    Nutt, D. J.
    [J]. PSYCHOPHARMACOLOGY, 2018, 235 (02) : 399 - 408
  • [5] Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study
    Carhart-Harris, Robin L.
    Bolstridge, Mark
    Rucker, James
    Day, Camilla M. J.
    Erritzoe, David
    Kaelen, Mendel
    Bloomfield, Michael
    Rickard, James A.
    Forbes, Ben
    Feilding, Amanda
    Taylor, David
    Pilling, Steve
    Curran, Valerie H.
    Nutt, David J.
    [J]. LANCET PSYCHIATRY, 2016, 3 (07): : 619 - 627
  • [6] Mental Health and Cardiovascular Disease
    Chaddha, Ashish
    Robinson, Elizabeth A.
    Kline-Rogers, Eva
    Alexandris-Souphis, Tina
    Rubenfire, Melvyn
    [J]. AMERICAN JOURNAL OF MEDICINE, 2016, 129 (11) : 1145 - 1148
  • [7] Association of Cigarette, Cigar, and Pipe Use With Mortality Risk in the US Population
    Christensen, Carol H.
    Rostron, Brian
    Cosgrove, Candace
    Altekruse, Sean F.
    Hartman, Anne M.
    Gibson, James T.
    Apelberg, Benjamin
    Inoue-Choi, Maki
    Freedman, Neal D.
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (04) : 469 - 476
  • [8] Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder A Randomized Clinical Trial
    Davis, Alan K.
    Barrett, Frederick S.
    May, Darrick G.
    Cosimano, Mary P.
    Sepeda, Nathan D.
    Johnson, Matthew W.
    Finan, Patrick H.
    Griffiths, Roland R.
    [J]. JAMA PSYCHIATRY, 2021, 78 (05) : 481 - 489
  • [9] Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews
    dos Santos, Rafael G.
    Carlos Bouso, Jose
    Angel Alcazar-Corcoles, Miguel
    Hallak, Jaime E. C.
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2018, 11 (09) : 889 - 902
  • [10] Psychedelics as anti-inflammatory agents
    Flanagan, Thomas W.
    Nichols, Charles D.
    [J]. INTERNATIONAL REVIEW OF PSYCHIATRY, 2018, 30 (04) : 363 - 375